88.9%
melanomastage III/IV melanomaAnti-programmed cell death protein 1 (PD-1) immunotherapyICR
…his study showed that a substantial proportion of patients with melanoma receiving anti-PD-1 therapy in the adjuvant (47.1%) and advance…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: stage III/IV melanoma ×
stage III/IV melanoma
This disease is selected. Its supporting articles are shown below.